Geneos Wealth Management’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2K Hold
1,386
﹤0.01% 1809
2025
Q4
$36.8K Sell
1,386
-48
-3% -$1.3K ﹤0.01% 1506
2025
Q3
$43.1K Sell
1,434
-53
-4% -$1.82K ﹤0.01% 1442
2025
Q2
$62.4K Sell
1,487
-916
-38% -$33.1K ﹤0.01% 1454
2025
Q1
$75.4K Buy
2,403
+1,382
+135% +$51.8K ﹤0.01% 1705
2024
Q4
$35.3K Sell
1,021
-60
-6% -$1.75K ﹤0.01% 1457
2024
Q3
$24.8K Buy
1,081
+11
+1% +$268 ﹤0.01% 1483
2024
Q2
$28.2K Buy
1,070
+10
+0.9% +$240 ﹤0.01% 1249
2024
Q1
$23.1K Buy
1,060
+69
+7% +$1.47K ﹤0.01% 1310
2023
Q4
$20.6K Sell
991
-2
-0.2% -$34 ﹤0.01% 1342
2023
Q3
$15K Sell
993
-62
-6% -$919 ﹤0.01% 1458
2023
Q2
$14K Buy
1,055
+27
+3% +$365 ﹤0.01% 1482
2023
Q1
$15.2K Sell
1,028
-552
-35% -$7.83K ﹤0.01% 1431
2022
Q4
$17.6K Sell
1,580
-36
-2% -$362 ﹤0.01% 1369
2022
Q3
$13K Sell
1,616
-2,912
-64% -$30.3K ﹤0.01% 1448
2022
Q2
$45K Sell
4,528
-190
-4% -$2.21K ﹤0.01% 1326
2022
Q1
$61K Buy
+4,718
New +$71K ﹤0.01% 1291

Other funds holding KD

Geneos Wealth Management's KD Position: Q1 2026 in Review

Geneos Wealth Management held its Kyndryl (KD) position steady in Q1 2026 at 1,386 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Geneos Wealth Management first reported a position in KD in Q1 2022 and has held it in 17 quarters since. The position peaked at $75.4K in Q1 2025. 660 funds tracked by Wall St. Rank hold KD as of Q1 2026.

  • Geneos Wealth Management held 1,386 shares of Kyndryl worth $18.2K as of Q1 2026.
  • Geneos Wealth Management left its Kyndryl share count unchanged in Q1 2026.
  • Kyndryl made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1809 holding.
  • Geneos Wealth Management first reported a position in Kyndryl in Q1 2022 and has held it in 17 quarters since.
  • Geneos Wealth Management's Kyndryl position peaked at $75.4K in Q1 2025.
  • 660 funds tracked by Wall St. Rank held Kyndryl as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.